|
Volumn 31, Issue 3, 2001, Pages 239-253
|
Narrowing the gap in treatment of depression
a a a a a a |
Author keywords
Depression; Health services accessibility; Time factors
|
Indexed keywords
AMFEBUTAMONE;
AMITRIPTYLINE;
AMOXAPINE;
ANTIDEPRESSANT AGENT;
CLOMIPRAMINE;
DESIPRAMINE;
DOXEPIN;
FLUOXETINE;
FLUVOXAMINE;
IMIPRAMINE;
ISOCARBOXAZID;
MAPROTILINE;
MIRTAZAPINE;
NEFAZODONE;
NORTRIPTYLINE;
PAROXETINE;
PHENELZINE;
PROTRIPTYLINE;
SERTRALINE;
TRANYLCYPROMINE;
TRAZODONE;
TRIMIPRAMINE;
VENLAFAXINE;
ADULT;
AGED;
AMBULATORY CARE;
ARTICLE;
CLINICAL PRACTICE;
CONSULTATION;
CONTROLLED STUDY;
DEPRESSION;
DRUG EFFICACY;
FEMALE;
HEALTH CARE ACCESS;
HEALTH SURVEY;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
MEDICAL PRACTICE;
MENTAL HEALTH CARE;
OUTPATIENT DEPARTMENT;
PRESCRIPTION;
PSYCHIATRIC DIAGNOSIS;
PSYCHOTHERAPY;
ADOLESCENT;
ADULT;
AGED;
ANTIDEPRESSIVE AGENTS;
COMBINED MODALITY THERAPY;
COST OF ILLNESS;
DEPRESSION;
FEMALE;
HUMANS;
INCIDENCE;
INSURANCE, HEALTH;
MALE;
MIDDLE AGED;
OFFICE VISITS;
PHYSICIAN-PATIENT RELATIONS;
PSYCHOTHERAPY;
|
EID: 0035704121
PISSN: 00912174
EISSN: None
Source Type: Journal
DOI: 10.2190/Q3VY-T8V9-30MA-VC5C Document Type: Article |
Times cited : (39)
|
References (24)
|